Cellcept

Mylan Receives Final FDA Approvals for Generic Versions of Anti-Rejection Medication CellCept(R)

...f organ rejection in patients receiving kidney, heart or liver transplants. cellcept Tablets, 500 mg, and cellcept Capsules, 250 mg, had annual U.S. sales of approximately $680 million and $...

Uptake of Branded Agents Will Drive the Systemic Lupus Erythematosus Drug Market to Quadruple to $1.4 Billion in 2016

... Entry of Novel Therapies Including Rituxan/MabThera and Increased Uptake of cellcept Will Provide Effective Treatment Options, According to a New Report from Decision Resources WALTHAM, Mass., Feb. 25 /PRNewswire/...

Cellcept in Medical Technology

Early Results of the CellCept Spare the Nephron Study Examine Kidney Function

SAN FRANCISCO, May 07, 2007 /PRNewswire/ -- Interim results from a multicenter trial investigating a novel kidney-sparing treatment protocol using CellCept(R) (mycophenolate mofetil) were presented at the American Transplant Congress. This and other Spare the Nephron (STN) trials in kidney and liv...

Aspreva and Roche Announce Preliminary Results for Phase III Study Evaluating CellCept in Lupus Nephritis

VICTORIA, BC, Canada and BASEL, Switzerland, June 27 /CNW/ - Aspreva Pharmaceuticals Corporation (NASDAQ: ASPV; TSX: ASV) and Roche today released preliminary results for a clinical trial comparing CellCept (oral mycophenolate mofetil, MMF) to intravenous cyclophosphamide (IVC), which is the curren...

Lupus Foundation of America Statement on Results for Clinical Study of CellCept Released by Aspreva Pharmaceutical Company

Statement by Sandra C. Raymond, President & CEO of the Lupus Foundation of America, Inc. WASHINGTON, June 27, 2007 /PRNewswire-USNewswire/ -- The Lupus Foundation of America, Inc. and more than 1.5 million Americans with lupus have been awaiting the preliminary findings of the Phase III clinic...

CellCept(R) and a Reduced Level of CNI Shows Trend Towards Preservation of Kidney Function Versus a Standard-Dose CNI

... level of CNI with a therapeutic monitored dose of cellcept is not inferior to that of a fixed dose of CellCep...hronic administration of CNI, facilitated a higher cellcept dosing without an overall increase in adverse even...ients administered either concentration-controlled cellcept and a reduced level of CNI, a concentration-contro...

Final Results of the CellCept(R) Spare the Nephron (STN) Study Show Maintenance Therapy is Associated with Improved Renal Function

...earson. "The STN Kidney studied the combination of cellcept and SRL with the goal of reducing CNI associated n...up. Safety outcomes were similar in both groups. cellcept is indicated for the prophylaxis of organ rejectio...ion. Physicians should inform female patients that cellcept use during pregnancy is associated with increased ...

Organ Donor Shortage Remains Obstacle for Would-Be Transplant Patients Despite Better Medicine

...ch prevent the immune system from rejecting a new organ, may have become victims of their own success. Medicines such as Astella's Prograf and Roche's cellcept have reduced incidence of acute organ rejection and made transplantation a viable option in more cases, thus increased organ waiting lists. Kidney acu...

Cellcept in Medical Dictionary

Dermatomyositis

...cles as well as the skin. ... Dermatomyositis can occur with other ... ... News for Updates. Home>Diseases >DM. Dermatomyositis (DM) ... cellcept Has Risks in Dermatomyositis 7/06. Altered protein Related to Autoimmune Diseases 3/06 ... Dermatomyositis ... In those with dermatomyositi...